Pathways Up-regulated in Alveolar Macrophages Post Challenge (n = 30) |
FDR |
Class a1 rhodopsin like receptors |
0 |
G-protein coupled receptor (GPCR) ligand binding |
0 |
Cytokine cytokine receptor interaction |
0 |
Allograft rejection |
0 |
Inflammatory response |
0 |
Hematopoietic cell lineage |
0 |
Suppressed in response to AZM |
0 |
Induced in response to IL-4 |
0 |
Signaling by GPCR |
0 |
Neuroactive ligand receptor interaction |
0 |
GPCR downstream signaling |
0 |
Suppressed in response to MP |
0 |
IL-2 Stat5 signaling |
0 |
Chemokine receptors bind chemokines |
0 |
TNFa signaling via NF-kB |
0 |
Immunoregulatory interactions between a lymphoid and a non lymphoid cell |
0 |
Peptide ligand binding receptors |
0 |
Gastrin creb signaling pathway via PKC and MAPK |
0 |
Induced in response to IL-10 |
0 |
G alpha (q) signaling events |
0 |
CDB T-cell receptor pathway |
3.68×10−5
|
Srp-dependent cotranslational protein targeting to membrane |
3.51×10−5
|
Core matrisome |
1.01×10−4
|
G2M checkpoint |
1.28×10−4
|
CDB T-cell receptor downstream pathway |
2.18×10−4
|
T-cell receptor signaling pathway |
2.71×10−4
|
IL-12 pathway |
5.54×10−4
|
T cytotoxic pathway |
1.06×10−3
|
T-cell signal transduction |
1.12×10−3
|
IL-17 pathway |
1.73×10−3
|
Pathways Down-regulated in Alveolar Macrophages Post Challenge (n = 30) |
FDR |
Generic transcription pathway |
0 |
Interferon alpha response |
0 |
Oxidative phosphorylation |
0 |
Metabolism of lipids and lipoproteins |
0 |
Suppressed in response to IL-4 |
0 |
Fatty acid metabolism |
0 |
Adipogenesis |
0 |
Peroxisome |
0 |
Induced in response to MP |
0 |
Interferon gamma response |
0 |
Cholesterol homeostasis |
0 |
Cholesterol biosynthesis |
0 |
Induced in response to AZM |
0 |
Pyruvate metabolism |
0 |
Transcription |
0 |
Aminoacyl tRNA biosynthesis |
0 |
Phospholimetabolism |
0 |
DNA repair |
6.40×10−5
|
p53 pathway |
6.06×10−5
|
Coagulation |
5.76×10−5
|
Spliceosome |
5.48×10−5
|
Valine leucine and isoleucine degradation |
5.23×10−5
|
Recruitment of mitotic centrosome proteins and complexes |
5.01×10−5
|
Interferon alpha beta signaling |
9.89×10−5
|
Platelet sensitization by LDL |
2.38×10−4
|
mRNA processing |
5.07×10−4
|
Antigen processing ubiquitination proteasome degradation |
4.88×10−4
|
Interferon gamma signaling |
5.13×10−4
|
Suppressed in response to IL-10 |
6.79×10−4
|
Glycan degradation |
9.73×10−4
|